Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

Comparing bone marrow and fat tissue injections for knee osteoarthritis treatment

Official title: Bone Marrow vs Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis: Randomized Clinical Trial

Run by Istituto Ortopedico Rizzoli · NCT06040957 · Data updated 2026-11-12

This study is testing whether injections of bone marrow or fat tissue can help people with knee osteoarthritis feel better and improve their condition over a year.

More Knee Osteoarthritis trials

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment204 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJanuary 8, 2024
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedFebruary 20, 2026
Trial IDNCT06040957 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women aged 40 to 75 with symptomatic unilateral knee osteoarthritis who have not benefited from conservative treatments.

Probably not a fit

Patients with significant knee deformities, recent knee surgeries, or other knee injuries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the safety and effectiveness of two different cellular products, bone marrow aspirate concentrate (BMAC) and minimally manipulated adipose tissue (MM-AT), for treating knee osteoarthritis. Patients with symptomatic unilateral knee OA will be randomly assigned to receive either BMAC or MM-AT through a single intra-articular injection. The study will assess clinical outcomes and potential disease-modifying effects over a 12-month follow-up period using imaging and biological assessments. Additionally, factors influencing treatment response will be analyzed to better understand the efficacy of these interventions.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from knee osteoarthritis.

How similar studies have gone: Other studies have shown promise in using similar cellular therapies for joint conditions, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients with symptomatic unilateral knee OA with:

1. Men or women aged 40 to 75 years;
2. Signs and symptoms of OA with a clinical history of gonalgia or swelling for at least 6 months;
3. Radiographic signs of OA (Kellgren-Lawrence grade 1-4);
4. No benefit after at least 4 months of conservative treatment;
5. Ability and consent of patients to actively participate in clinical and radiological (rx and MRI) follow-up;
6. Signing of informed consent.

Exclusion Criteria:

1. Patients unable to express consent;
2. Patients aged \< to 40 and \> to 75 years;
3. Patients with axial deviations \> 5°;
4. Patients who have suffered trauma or undergone intra-articular infiltration of other substance in the previous 6 months;
5. Patients who have undergone knee surgery in the previous 12 months;
6. Patients with concomitant knee injuries causing joint pain or swelling (-focal full-thickness osteochondral defects, acute meniscal injuries);
7. Patients with malignant neoplasms;
8. Patients with uncompensated systemic diseases (rheumatic diseases, metabolic disorders such as diabetes and thyroid diseases);
9. Patients with infectious diseases;
10. Patients with histories of alcohol or drug abuse;
11. Patients who are pregnant;
12. Patients with allergies to anesthetics used in the procedure.

Where it's running

  • Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Luca Andriolo, MD — Istituto Ortopedico Rizzoli - II Clinica Ortopedica e Traumatologica
  • Study coordinator: Luca Andriolo, MD
  • Email: luca.andriolo@ior.it
  • Phone: 6366567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.